Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MDCO: Medicines Company -- Ignore unavailable to you. Want to Upgrade?

To: Mike who wrote (80)	5/11/2003 9:09:38 AM
From: Mike	Respond to of 125

Earnings estimates from Zacks.com below. my.zacks.com Pretty wide range for '04. I think we are going to have to see how the next two qtrs play out to see where we may land. My contention has been that the sales estimates for this company have been low. Current running rate for sales is around $5mm/month. If we see a running rate above $6MM/month will be a nice milestone to break. Only four analyst follow MDCO but this is nice to see below. Average rating is a strong buy on the stock. my.zacks.com I have spoken with two of the analysts directly but have not been successful talking with them about '04. my.zacks.com Here's the key item below. biz.yahoo.com This is the sales estimates. I think even the high estimate for '04 will be exceeded if the open heart application goes well. Good investing, Mike